SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-033500
Filing Date
2024-04-16
Accepted
2024-04-16 17:00:05
Documents
6
Period of Report
2024-04-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0203892-6k_altamira.htm 6-K 9663
2 NOTICE TO SHAREHOLDERS DATED MAY 16, 2024 ea020389201ex99-1_altamira.htm EX-99.1 40480
3 PROXY CARD FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS ea020389201ex99-2_altamira.htm EX-99.2 1665
4 GRAPHIC ex99-1_001.jpg GRAPHIC 8375
5 GRAPHIC ex99-2_001.jpg GRAPHIC 163452
6 GRAPHIC ex99-2_002.jpg GRAPHIC 135733
  Complete submission text file 0001213900-24-033500.txt   477118
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 24848540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)